# FDA Inspection 820594 - Forrest General Cancer Center - February 28, 2013

Source: https://www.keypedia.com/records/fda_inspections/forrest-general-cancer-center/99655cfe-e397-4ee8-bb73-6f5af07f042d
Source feed: FDA_Inspections

> FDA Inspection 820594 for Forrest General Cancer Center on February 28, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 820594
- Company Name: Forrest General Cancer Center
- Inspection Date: 2013-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1100765 - 2019-08-15](https://www.keypedia.com/records/fda_inspections/forrest-general-cancer-center/6c4269d1-8424-4900-839e-1ad67c7fda87)
- [FDA Inspection 1019550 - 2017-07-06](https://www.keypedia.com/records/fda_inspections/forrest-general-cancer-center/e1dedac7-98d7-46fb-b76c-1c689489820b)
- [FDA Inspection 923677 - 2015-04-21](https://www.keypedia.com/records/fda_inspections/forrest-general-cancer-center/eb82a5bd-d11a-42a6-ab80-86f86cc874c8)
- [FDA Inspection 746034 - 2011-09-20](https://www.keypedia.com/records/fda_inspections/forrest-general-cancer-center/1078f69e-5357-4208-8e3f-0a567fa61b2b)
- [FDA Inspection 656631 - 2010-04-07](https://www.keypedia.com/records/fda_inspections/forrest-general-cancer-center/45981465-1fc7-47d1-9b52-db9747e2bbf0)

Company: https://www.keypedia.com/companies/forrest-general-cancer-center/1ef6534a-f7ae-4f18-b3e5-a7d235704b03

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d